Breaks Categories: News

MondayAug 05, 2019 10:22 am

NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Reports Positive Preliminary Data from Phase I Clinical Trial of INB03

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today reported positive preliminary data during a presentation at Cambridge Healthtech Institute’s Seventh Annual Immuno-Oncology Summit in Boston. Per the update, the company’s INB03 is being developed as part of combination immunotherapy to potentially reverse resistance to treatment. In the open-label, dose-escalation Phase I trial, patients with advanced solid tumors received INB03, a novel, second-generation soluble TNF (tumor necrosis factor) inhibitor that works by a dominant-negative technology. Positive preliminary data from the first two cohorts were released today,…

Continue Reading

MondayAug 05, 2019 9:53 am

NetworkNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Launches “Rainbow Dreams” – A New Line of Flavored CBD & THC Oil Infused Vaporization CCell Cartridges

California-based Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), this morning announced the launch of its unique line of newly formulated and flavored cannabis oil infused CDB and THC vaporization cartridges branded as “Rainbow Dreams.” According to the update, the new product line includes a formulated CBD heavy 3:1 vaporization cartridge for customers that need pain relief but prefer minimal THC impact. Each of the four new Grapefruit Rainbow Dream vape cartridges will have its own unique flavor profile, from mango passion to citrus bliss, paired to a complimentary cannabis strain including Durban Poison, Cannatonic and OG…

Continue Reading

FridayAug 02, 2019 11:33 am

NetworkNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Receives Subscriptions for $1,325,000 Convertible Debenture Financing

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) this morning announced its receipt of subscriptions for a convertible debenture financing in the amount of $1,325,000. Per the update, the debentures will have a maturity date of two years from the Offering’s closing date (“Maturity Date”), and will bear interest from the date of closing at 10 percent per annum, payable monthly. At the option of the holder, the debentures will be convertible into units of the company at any time prior to the close of business on the last business day immediately preceding the Maturity Date at a conversion price of…

Continue Reading

FridayAug 02, 2019 11:03 am

NetworkNewsBreaks – Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) to Host August 8 Conference Call and Webcast to Discuss Q2 2019 Results

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) today announced that it will host a conference call and live audio webcast to provide a corporate update and discuss operational and financial results for the quarter ended June 30, 2019. The call is scheduled to be held at 8:30 a.m. Eastern Time on Thursday, August 8, 2019, and will be led by Corbus Chief Executive Officer Yuval Cohen, Ph.D., joined with additional members of the company’s management team. Interested participants and investors may access the call by dialing (877) 407-3978 (domestic) or (412) 902-0039 (international). The live webcast will be accessible on the…

Continue Reading

FridayAug 02, 2019 10:36 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Completes Successful Renewal of Health Canada Licenses for Ancaster Site

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced its successful renewal of its Health Canada licenses for the company's Ancaster, Ontario facility. According to the update and as per the Cannabis Regulations, these licenses authorize TGOD to cultivate, process and sell cannabis from its Ancaster site until August 2022. "From day one, the entire team at TGOD placed a strong focus on ethics and compliance. These core values have been paramount to our success," TGOD CEO Brian Athaide said in the news release. "Our team continues to work diligently as we ramp…

Continue Reading

FridayAug 02, 2019 9:52 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Retains Integra Consulting Group LLC to Provide Investor Relations Services

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that it has engaged Integra Consulting Group LLC to provide investor relations services to the company in compliance with regulatory guidelines. According to the update, Integra leverages decades of market experience with a robust proprietary database and partners with select underexposed and undervalued emerging growth companies to continuously maximize market visibility throughout their clients’ different development cycles. Integra will work with Lexaria to provide outreach to communicate its message to maximize corporate visibility, seek out opportunities to deliver audience-targeted presentations and utilize web-casting capabilities…

Continue Reading

ThursdayAug 01, 2019 12:52 pm

NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Health Canada Approval for Radicle’s Production Facility Expansion Project

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company Radicle Medical Marijuana Inc. has received Health Canada approval for its production facility expansion project. According to the update, the approval effectively doubles Radicle's production footprint, significantly increasing its yearly capacity to 6,000 kilograms. "We are thrilled with the continued growth happening at Radicle," Canopy Rivers President and CEO Narbe Alexandrian said in the news release. "The cannabis industry is showing many similarities to the craft beer movement, where local, artisanal operators are succeeding in securing loyal and robust customer followings. Radicle is thriving within this…

Continue Reading

ThursdayAug 01, 2019 12:08 pm

NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO to Present at Cambridge Healthcare Institute’s Seventh Annual Immuno-Oncology Summit

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Co-Founder and CEO RJ Tesi, M.D. will present at the Cambridge Healthcare Institute’s Seventh Annual Immuno-Oncology Summit. The event is taking place in Boston from August 5 through August 9, 2019, and Dr. Tesi’s presentations will include “Targeting Soluble TNF to Improve Efficacy of Combination Immunotherapy,” “Next-Generation Immunotherapies,” and “Targeting ‘Protector’ Cells of the Innate Immune System.” “We are committed to helping treatment-resistant patients by advancing the clinical development of combination therapies and…

Continue Reading

ThursdayAug 01, 2019 11:41 am

NetworkNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) CLR Roasters Hires Industry Veteran Omar Peraza

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that its CLR Roasters has hired 35-year industry veteran Omar Peraza to lead the company's food service expansion. According to the update, Peraza holds a global view of all aspects of the coffee industry, and his key areas of expertise include sales, sales management, service operations, institutional and office coffee sales, route sales, fleet management and major contract negotiations. "We are very excited to add Omar Peraza to our team here at CLR Roasters,” Ernesto Aguila, president and founder of CLR Roasters,…

Continue Reading

ThursdayAug 01, 2019 11:03 am

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Announces Commencement of Hemp Cultivation with Hempistry, Inc.

Sugarmade (OTCQB: SGMD) this morning announced commencement of hemp cultivation in conjunction with Hempistry, Inc., a Kentucky hemp cultivator for which Sugarmade recently announced it had begun to exercise its investment option. According to the update, the hemp being cultivated this year by Hempistry is a fast growing strain especially rich in cannabidiol (“CBD”). "Our investment in Hempistry, our commencement to the state of Kentucky and our pending acquisition of BZRTH provide Sugarmade with multiple options for growth, while our recently effective S-1 filing expands our ability to finance the many initiatives in front of the Company," SGMD CEO Jimmy…

Continue Reading